论文部分内容阅读
目的:引起临床医生对于帕金森病患者首发癫痫诊治的重视,促进临床药物的合理使用,以减少不良反应的发生.方法:临床药师从其发病机制、治疗方法和药学监护等方面对1例帕金森病首发癫痫患者进行综合分析.结果:对于抗帕金森治疗过程中发生的癫痫样发作与左旋多巴(L-dopa)导致的帕金森病药源性异动症难以区分,治疗方案难以把握;抗癫痫药物中丙戊酸(VPA)对帕金森综合征具有潜在的诱发或加重作用且起病不易察觉,临床易忽视.结论:在L-dopa治疗过程中应尽量避免帕金森药源性异动症的发生,合并首次癫痫发作的患者要加以区分,合理选用抗癫痫药物治疗.“,”Objective:To bring to doctors’ attention to the first time attack of epilepsy in the patients with Parkinson’ s disease, enhance the rational drug use and reduce the occurrence of adverse reactions in clinics. Methods: A Parkinson patient with the first time attack of epilepsy was synthetically analyzed on the mechanism of disease, therapy regimen and pharmaceutical care. Results:It was difficult to distinguish the symptom of epilepsy during the treatment of Parkinson’ s disease from that of L-dopa induced dyskinesia, therefore, the suitable treatment was difficult to perform. Moreover, antiepileptic drug valproic acid could aggravate Parkinson syn-drome imperceptibly, which was easy to be ignored in clinics. Conclusion:L-dopa induced dyskinesia should try to avoid during the treatment of Parkinson, and should distinguish from the first time attack of epilepsy in order to choose proper antiepileptic drugs.